Policy & Medicine - Legal, Regulatory, and Compliance Issues

As part of Harvard University’s lecture series on Institutional Corruption at the Edmond J. Sarfa Foundation Center for Ethics,…

Continuing Harvard University’s lecture series on Institutional Corruption at the Edmond J. Sarfa Foundation Center for Ethics,…

Over the next few days we will be posting articles based on a series of lectures that were presented at Harvard University earlier…

Hospital acquired infections (HAIs) cost millions of dollars each year, and result in the deaths of hundreds of thousands of…

Last week, shortly after the Senate passed legislation that would temporarily “fix” the susbtainable growth rate (SGR) problem for…

With Senator Charles Grassley (R-IA) set to leave as Ranking Member of the Senate Finance Committee to take over as Ranking Member…

Last month, Food and Drug Administration (FDA) Deputy Chief for Litigation Eric Blumberg told Bloomberg news that, “Drugmaker…

Over the past several months, in anticipation of the upcoming changes to the FDA’s 510(k) approval program, policymakers and the…

After Massachusetts published the last ½ of 2009 data on industry payments from pharmaceutical and device companies to physicians…

With the amount of negative attention lately surrounding relationships between physicians and industry, some doctors have had…